bioMérieux (BMXMF) News Today $118.91 0.00 (0.00%) As of 02/21/2025 Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period bioMérieux S.A. (OTCMKTS:BMXMF) Sees Large Drop in Short InterestbioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) was the recipient of a large decline in short interest during the month of January. As of January 31st, there was short interest totalling 104,300 shares, a decline of 10.2% from the January 15th total of 116,100 shares. Based on an average daily trading volume, of 4,900 shares, the days-to-cover ratio is currently 21.3 days.February 17, 2025 | marketbeat.combioMérieux (OTCMKTS:BMXMF) Reaches New 1-Year High - Time to Buy?bioMérieux (OTCMKTS:BMXMF) Reaches New 1-Year High - Should You Buy?February 4, 2025 | marketbeat.combioMérieux S.A. (OTCMKTS:BMXMF) Sees Significant Decrease in Short InterestbioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) was the target of a large decrease in short interest during the month of January. As of January 15th, there was short interest totalling 118,300 shares, a decrease of 19.1% from the December 31st total of 146,200 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is presently 1,183.0 days.January 30, 2025 | marketbeat.comL'objectif de cours de BioMerieux relevé, recommandation d'achat sur des résultats solides au T4January 22, 2025 | fr.investing.comBioMerieux stock target upgraded, buy rating on robust Q4 resultsJanuary 22, 2025 | msn.combioMérieux S.A. (OTCMKTS:BMXMF) Short Interest UpdatebioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) saw a significant decrease in short interest in December. As of December 31st, there was short interest totalling 118,300 shares, a decrease of 19.1% from the December 15th total of 146,200 shares. Based on an average trading volume of 100 shares, the short-interest ratio is presently 1,183.0 days.January 16, 2025 | marketbeat.combioMérieux S.A. (OTCMKTS:BMXMF) Sees Significant Growth in Short InterestbioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) was the target of a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 139,000 shares, a growth of 6.6% from the November 15th total of 130,400 shares. Based on an average trading volume of 100 shares, the short-interest ratio is presently 1,390.0 days.December 15, 2024 | marketbeat.comRBC Capital attribue une note de surperformance à l'action BioMerieuxDecember 11, 2024 | fr.investing.combioMérieux (OTCMKTS:BMXMF) Shares Up 3% - What's Next?bioMérieux (OTCMKTS:BMXMF) Shares Up 3% - Time to Buy?November 30, 2024 | marketbeat.combioMérieux (OTCMKTS:BMXMF) Stock Crosses Below Fifty Day Moving Average - What's Next?bioMérieux (OTCMKTS:BMXMF) Stock Price Crosses Below 50 Day Moving Average - Here's What HappenedNovember 8, 2024 | marketbeat.combioMérieux S.A. (OTCMKTS:BMXMF) Short Interest Down 20.2% in OctoberbioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) was the target of a significant decline in short interest during the month of October. As of October 15th, there was short interest totalling 128,700 shares, a decline of 20.2% from the September 30th total of 161,300 shares. Based on an average trading volume of 5,000 shares, the days-to-cover ratio is presently 25.7 days.October 28, 2024 | marketbeat.comLe large parc installé de BioMerieux considéré comme un avantage clé - HSBCOctober 17, 2024 | fr.investing.combioMérieux (OTCMKTS:BMXMF) Stock Crosses Below 50 Day Moving Average - Time to Sell?bioMérieux (OTCMKTS:BMXMF) Share Price Crosses Below 50 Day Moving Average - Time to Sell?October 9, 2024 | marketbeat.comShort Interest in bioMérieux S.A. (OTCMKTS:BMXMF) Drops By 26.8%bioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) saw a significant decline in short interest in September. As of September 15th, there was short interest totalling 165,200 shares, a decline of 26.8% from the August 31st total of 225,800 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 1,652.0 days.September 28, 2024 | marketbeat.combioMérieux S.A. (BMXMF)September 18, 2024 | finance.yahoo.combioMérieux (OTCMKTS:BMXMF) Hits New 12-Month High at $122.52bioMérieux (OTCMKTS:BMXMF) Reaches New 12-Month High at $122.52September 11, 2024 | marketbeat.comBerenberg Bank Keeps Their Buy Rating on bioMerieux (0RUG)September 11, 2024 | markets.businessinsider.comKepler Capital Reaffirms Their Buy Rating on bioMerieux (0RUG)September 7, 2024 | markets.businessinsider.comUBS maintient sa note d'achat sur BioMerieux, voit la force de la R&DSeptember 6, 2024 | fr.investing.combioMérieux (OTCMKTS:BMXMF) Hits New 12-Month High at $120.00bioMérieux (OTCMKTS:BMXMF) Sets New 52-Week High at $120.00September 5, 2024 | marketbeat.combioMérieux (OTCMKTS:BMXMF) Hits New 52-Week High at $119.62bioMérieux (OTCMKTS:BMXMF) Reaches New 52-Week High at $119.62August 28, 2024 | marketbeat.combioMerieux (0RUG) Gets a Buy from Kepler CapitalAugust 28, 2024 | markets.businessinsider.comHologic Has A Lot Of Fine Qualities, But A Discount Valuation Isn't Among ThemAugust 27, 2024 | seekingalpha.comUBS Group Upgrades bioMérieux (OTCMKTS:BMXMF) to "Strong-Buy"UBS Group upgraded shares of bioMérieux to a "strong-buy" rating in a research note on Thursday.August 24, 2024 | marketbeat.comUBS voit l'action BioMerieux prête à croître grâce à la plateforme disruptive SPOTFIREAugust 22, 2024 | fr.investing.comBaxter International Inc. (BAX)July 27, 2024 | finance.yahoo.comBioMerieux SA BIMMay 17, 2024 | morningstar.comBMXMF bioMérieux S.A.May 8, 2024 | seekingalpha.comBiomerieux/adr's Net WorthMarch 6, 2024 | benzinga.comOxford Nanopore Shares Rise on Backed Guidance, GBP70 Mln Investment by bioMerieuxOctober 19, 2023 | marketwatch.combioMerieux : les résultats 2022 devraient se situer dans la borne haute des intervalles publiés en aoûtOctober 26, 2022 | msn.combioMerieux : du mieuxApril 13, 2022 | msn.combioMerieux recule après les annoncesApril 12, 2022 | msn.combioMérieux S.A. GAAP EPS of €5.06, revenue of €3.37MMarch 3, 2022 | seekingalpha.comFrench multidisciplinary consortium ARPEGE awarded public funding of close to €9 million to fight antibiotic resistanceJanuary 7, 2022 | finance.yahoo.comBaxter and bioMérieux Announce CE Mark for NEPHROCLEAR™ CCL14 Test to Predict Persistent Severe Acute Kidney InjuryOctober 21, 2021 | finance.yahoo.combioMerieux to Exhibit at SupplySide West 2021 at Mandalay Bay in Las Vegas Oct. 25-28, 2021October 5, 2021 | finance.yahoo.com Get bioMérieux News Delivered to You Automatically Sign up to receive the latest news and ratings for BMXMF and its competitors with MarketBeat's FREE daily newsletter. Email Address BMXMF Media Mentions By Week BMXMF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMXMF News Sentiment▼1.830.60▲Average Medical News Sentiment BMXMF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMXMF Articles This Week▼10▲BMXMF Articles Average Week Get bioMérieux News Delivered to You Automatically Sign up to receive the latest news and ratings for BMXMF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GLNCY News Today BMWYY News Today ADYEY News Today MHVYF News Today CAIXY News Today JAPAY News Today EXPGY News Today BAESY News Today BAMXF News Today DHLGY News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BMXMF) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioMérieux S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share bioMérieux With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
